CFIR construct | Example for beta-lactam TDM |
---|---|
Intervention characteristics The intervention being implemented in an organization | Processes for specimen collection |
Turnaround time | |
Results reporting in the electronic health record | |
Outer setting Economic, political, social context within which the organization exists | Statements from professional organizations encouraging beta-lactam TDM (e.g., SCCM, ESICM, ESCMID) |
Global emphasis on personalized medicine | |
Inner setting Structural, political, and cultural contexts through which implementation occurs | Academic environment at the hospital |
Multiple providers from various disciplines caring for the same patient (e.g., ICU, pharmacist, ID) | |
Individuals Individuals involved with implementation | Knowledge about antibiotic TDM |
Belief in the ability to execute beta-lactam TDM in clinical practice | |
Early versus late adopter (Rogers Diffusion of Innovation) | |
Process Implementation process | Stakeholder engagement in creation of the workflow |
Development of an implementation toolkit | |
Local champions who are early users |